Cargando…

The Sp1/FOXC1/HOTTIP/LATS2/YAP/β‐catenin cascade promotes malignant and metastatic progression of osteosarcoma

The prognosis for osteosarcoma (OS) is dismal due to the aggressive tumor growth and high incidence of metastasis. The long noncoding RNA human homeobox A transcript at the distal tip (HOTTIP) and the transcription factor forkhead box C1 (FOXC1) present oncogenic activities in OS. Here, we aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ke, Ni, Jiang‐Dong, Li, Wen‐Zhao, Pan, Bai‐Qi, Yang, Yu‐Ting, Xia, Qin, Huang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530777/ https://www.ncbi.nlm.nih.gov/pubmed/32634265 http://dx.doi.org/10.1002/1878-0261.12760

Ejemplares similares

The TGF(β)→TAK1→LATS→YAP1 Pathway Regulates the Spatiotemporal Dynamics of YAP1
por: Kim, Min-Kyu, et al.
Publicado: (2023)

Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade
por: Lodge, Emily J, et al.
Publicado: (2019)

FOXC2 augments tumor propagation and metastasis in osteosarcoma
por: Gozo, Maricel C., et al.
Publicado: (2016)

PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells
por: Hein, Ashley L., et al.
Publicado: (2019)

Calotropin activates YAP through downregulation of LATS1 in colorectal cancer cells
por: Zhou, Limin, et al.
Publicado: (2019)

FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer
por: Hsu, Hsi-Hsien, et al.
Publicado: (2019)

OR24-4 Homeostatic and Tumourigenic Activity of SOX2+ Pituitary Stem Cells is Controlled by the LATS/YAP/TAZ Cascade
por: Lodge, Emily, et al.
Publicado: (2019)

NRP1 transduces mechanical stress inhibition via LATS1/YAP in hypertrophic scars
por: Li, Mengzhi, et al.
Publicado: (2023)

Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells
por: Darbankhales, Soroush, et al.
Publicado: (2020)

HOTTIP polymorphism may affect gastric cancer susceptibility by altering HOTTIP expression
por: Wang, Ben-gang, et al.
Publicado: (2020)

FOXC1 silencing inhibits the epithelial-to-mesenchymal transition of glioma cells: Involvement of β-catenin signaling
por: Cao, Qinchen, et al.
Publicado: (2019)

Structural basis for Mob1-dependent activation of the core Mst–Lats kinase cascade in Hippo signaling
por: Ni, Lisheng, et al.
Publicado: (2015)

The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival
por: Godlewski, J., et al.
Publicado: (2018)

Foxc1 and Foxc2 in the Neural Crest Are Required for Ocular Anterior Segment Development
por: Seo, Seungwoon, et al.
Publicado: (2017)

Loss of Foxc1 and Foxc2 function in chondroprogenitor cells disrupts endochondral ossification
por: Almubarak, Asra, et al.
Publicado: (2021)

S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway
por: Tao, Yi-Ping, et al.
Publicado: (2023)

FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC
por: Cao, Sisi, et al.
Publicado: (2018)

Regulation and Function of FOXC1 in Osteoblasts
por: Suthon, Sarocha, et al.
Publicado: (2023)

Endothelial FOXC1 and FOXC2 promote intestinal regeneration after ischemia–reperfusion injury
por: Tan, Can, et al.
Publicado: (2023)

Irisin Ameliorates Intervertebral Disc Degeneration by Activating LATS/YAP/CTGF Signaling
por: Chen, Taiqiu, et al.
Publicado: (2022)

β-Arrestin 2 suppresses the activation of YAP by promoting LATS kinase activity
por: Kim, Minsuh, et al.
Publicado: (2022)

GABPB1-AS1 Promotes the Development of Osteosarcoma by Targeting SP1 and Activating the Wnt/β-Catenin Pathway
por: Chen, Jingyang, et al.
Publicado: (2022)

17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway
por: Ye, Xiang-Yun, et al.
Publicado: (2015)

The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
por: Sun, Dan, et al.
Publicado: (2020)

Prognostic value of the long noncoding RNA HOTTIP in human cancers
por: Li, Wei, et al.
Publicado: (2017)

FOXC1, the new player in the cancer sandbox
por: Elian, Fahed A., et al.
Publicado: (2017)

The Diverse Consequences of FOXC1 Deregulation in Cancer
por: Gilding, L. Niall, et al.
Publicado: (2019)

WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice
por: Park, Jaeoh, et al.
Publicado: (2020)

Molecular regulation of trophoblast stem cell self-renewal and giant cell differentiation by the Hippo components YAP and LATS1
por: Basak, Trishita, et al.
Publicado: (2022)

Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase–mediated inhibitory phosphorylation of the transcriptional coactivator YAP
por: Thines, Louise, et al.
Publicado: (2022)

Pharmacological Activation of YAP/TAZ by Targeting LATS1/2 Enhances Periodontal Tissue Regeneration in a Murine Model
por: Sato, Akiko, et al.
Publicado: (2023)

Shear stimulation of FOXC1 and FOXC2 differentially regulates cytoskeletal activity during lymphatic valve maturation
por: Norden, Pieter R, et al.
Publicado: (2020)

Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
por: Sun, Dan, et al.
Publicado: (2022)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Foxc1 and Foxc2 function in osteochondral progenitors for the progression through chondrocyte hypertrophy and mineralization of the primary ossification center
por: Almubarak, Asra, et al.
Publicado: (2023)

RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
por: Pan, Yi, et al.
Publicado: (2018)

Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway
por: Wang, Chien-Hao, et al.
Publicado: (2023)

FOXC1: an emerging marker and therapeutic target for cancer
por: Han, Bingchen, et al.
Publicado: (2017)

NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling
por: Yin, Lei, et al.
Publicado: (2019)

LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca(2+)-FAK signal pathway
por: Pan, Ke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_10474ls8ssfataqdhmk8avsu13